Cdx2 Controls Expression of the Protocadherin Mucdhl, an Inhibitor of Growth and β-Catenin Activity in Colon Cancer Cells

被引:42
作者
Hinkel, Isabelle [1 ,2 ]
Duluc, Isabelle [1 ,2 ]
Martin, Elisabeth [1 ,2 ]
Guenot, Dominique [2 ,3 ]
Freund, Jean-Noel [1 ,2 ]
Gross, Isabelle [1 ,2 ]
机构
[1] INSERM, U682, F-67200 Strasbourg, France
[2] Univ Strasbourg, Fac Med, F-67081 Strasbourg, France
[3] EA4438, F-67085 Strasbourg, France
关键词
Tumor Suppressor; cdhr5; Colorectal Cancer; CRC; HOMEOBOX GENE; COLORECTAL-CANCER; MU-PROTOCADHERIN; STEM-CELLS; INTESTINE; MOUSE; CADHERIN; PROTEINS; PROLIFERATION; TRANSCRIPTION;
D O I
10.1053/j.gastro.2011.12.037
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: The intestine-specific homeobox transcription factor Cdx2 is an important determinant of intestinal identity in the embryonic endoderm and regulates the balance between proliferation and differentiation in the adult intestinal epithelium. Human colon tumors often lose Cdx2 expression, and heterozygous inactivation of Cdx2 in mice increases colon tumorigenesis. We sought to identify Cdx2 target genes to determine how it contributes to intestinal homeostasis. METHODS: We used expression profiling analysis to identify genes that are regulated by Cdx2 in colon cancer cells lines. Regulation and function of a potential target gene were further investigated using various cell assays. RESULTS: In colon cancer cell lines, Cdx2 directly regulated the transcription of the gene that encodes the protocadherin Mucdhl. Mucdhl localized to the apex of differentiated cells in the intestinal epithelium, and its expression was reduced in most human colon tumors. Overexpression of Mucdhl inhibited low-density proliferation of colon cancer cells and reduced tumor formation in nude mice. One isoform of Mucdhl interacted with beta-catenin and inhibited its transcriptional activity. CONCLUSIONS: The transcription factor Cdx2 activates expression of the protocadherin Mucdhl, which interacts with beta-catenin and regulates activities of intestinal cells. Loss of Cdx2 expression in colon cancer cells might reduce expression of Mucdhl and thereby lead to tumor formation.
引用
收藏
页码:875 / U335
页数:14
相关论文
共 50 条
  • [31] LIN28B induces a differentiation program through CDX2 in colon cancer
    Suzuki, Kensuke
    Masuike, Yasunori
    Mizuno, Rei
    Sachdeva, Uma M.
    Chatterji, Priya
    Andres, Sarah F.
    Sun, Wenping
    Klein-Szanto, Andres J.
    Besharati, Sepideh
    Remotti, Helen E.
    Verzi, Michael P.
    Rustgi, Anil K.
    JCI INSIGHT, 2021, 6 (09)
  • [32] Mismatch repair phenotype determines the implications of tumor grade and CDX2 expression in stage II-III colon cancer
    Hestetun, Kjersti Elvestad
    Aasebo, Kristine
    Rosenlund, Nina Benedikte
    Mueller, Yvonne
    Dahl, Olav
    Myklebust, Mette Pernille
    MODERN PATHOLOGY, 2021, 34 (01) : 161 - 170
  • [33] HOXB4 Gene Expression Is Regulated by CDX2 in Intestinal Epithelial Cells
    Jorgensen, Steffen
    Coskun, Mehmet
    Homburg, Keld Mikkelsen
    Pedersen, Ole B. V.
    Troelsen, Jesper T.
    PLOS ONE, 2016, 11 (10):
  • [34] SATB2 and CDX2 are prognostic biomarkers in DNA mismatch repair protein deficient colon cancer
    Ma, Changqing
    Olevian, Dane
    Miller, Caitlyn
    Herbst, Cameron
    Jayachandran, Priya
    Kozak, Margaret M.
    Chang, Daniel T.
    Pai, Reetesh K.
    MODERN PATHOLOGY, 2019, 32 (08) : 1217 - 1231
  • [35] Prognostic impact of CDX2 in stage II colon cancer: results from two nationwide cohorts
    Hansen, Torben Frostrup
    Kjaer-Frifeldt, Sanne
    Eriksen, Ann Christina
    Lindebjerg, Jan
    Jensen, Lars Henrik
    Sorensen, Flemming Brandt
    Jakobsen, Anders
    BRITISH JOURNAL OF CANCER, 2018, 119 (11) : 1367 - 1373
  • [36] CDX2 prognostic value in stage II/III resected colon cancer is related to CMS classification
    Pilati, C.
    Taieb, J.
    Balogoun, R.
    Marisa, L.
    de Reynies, A.
    Laurent-Puig, P.
    ANNALS OF ONCOLOGY, 2017, 28 (05) : 1032 - 1035
  • [37] CDX2 serves as a Wnt signaling inhibitor and is frequently methylated in lung cancer
    Liu, Xuefeng
    Zhang, Xiaomei
    Zhan, Qimin
    Brock, Malcolm V.
    Herman, James G.
    Guo, Mingzhou
    CANCER BIOLOGY & THERAPY, 2012, 13 (12) : 1152 - 1157
  • [38] CDX2 Protein Expression in Colorectal Cancer and ItsCorrelation with Clinical and Pathological Characteristics, Prognosis, and Survival Rate of Patients
    Asgari-Karchekani, Shafigheh
    Karimian, Mohammad
    Mazoochi, Tahereh
    Taheri, Maryam Akhavan
    Khamehchian, Tahereh
    JOURNAL OF GASTROINTESTINAL CANCER, 2020, 51 (03) : 844 - 849
  • [39] Quantitative analysis of CDX2 protein expression improves its clinical utility as a prognostic biomarker in stage II and III colon cancer
    den Uil, Sjoerd H.
    de Wit, Meike
    Slebos, Robbert J. C.
    Delis-van Diemen, Pien M.
    Sanders, Joyce
    Piersma, Sander R.
    Pham, Thang V.
    Coupe, Veerle M. H.
    Bril, Herman
    Stockmann, Hein B. A. C.
    Jimenez, Connie R.
    Meijer, Gerrit A.
    Fijneman, Remond J. A.
    EUROPEAN JOURNAL OF CANCER, 2021, 144 : 91 - 100
  • [40] The intestine-specific transcription factor Cdx2 inhibits β-catenin/TCF transcriptional activity by disrupting the β-catenin-TCF protein complex
    Guo, Rong-Jun
    Funakoshi, Shinsuke
    Lee, Hannah H.
    Kong, Jianping
    Lynch, John P.
    CARCINOGENESIS, 2010, 31 (02) : 159 - 166